Condition: Facet Joints; Degeneration · Back Pain · Facet Joint Pain · Sponsor: Alimorad Farshchian
The purpose of this study is to see if the use of Alocyte (cord blood plasma plus mononucleic cells) will be safe, well tolerated, and whether it causes any side effects. The study will also examine if the use of the Investigational Product (IP) is able to reduce local inflammation or alleviate Facetogenic back pain
This description comes directly from the study's public registry record.
Ileana Simon, RN · 3058914686 · ileana@genorthix.com
Alimorad Farshchian, MD · 3058914686 · genorthix@yahoo.com
Always discuss trial participation with your own doctor first.
| The Center for Regenerative Medicine | North Miami, Florida, United States | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05909709